(Sharecast News) - GSK unveiled sweeping cost-saving plans on Tuesday as part of moves to ramp up research and development, including a £400m investment in the UK.
The blue chip pharma announced a three-year programme targeting £1.9bn of annual savings by 2029. Chief executive Luke Miels said the drive, which will...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE